Please check the individual session for location or broadcast availability.
Benjamin Musher, MD
Target Audience and Needs
Gastroenterologists, hepatologists, medical oncologists, surgical oncologists, thoracic surgeons, radiologists, pathologists, radiation oncologists, physician assistants, nurse practitioners, fellows, residents, and medical students need to receive regular updates on advances in the surgical and radiotherapeutic management of gastrointestinal cancer. The tumor board aims to advance the knowledge of learners regarding the fundamentals of tumor biology and the effects of tumor biology on treatment decisions. The tumor board also aims to promote a collaborative approach to complex cancer care, enhance the quality of gastrointestinal cancer care, and improve patient outcomes.
Educational methods will include lectures, case presentations, and literature review.
At the conclusion of the sessions, the participants should be able to:
- Recognize the complexity of gastrointestinal oncologic care and the need for a multi-specialty team.
- Describe the central role tumor boards play in devising, coordinating, and executing complex oncologic care plans.
- Demonstrate greater understanding of the fundamentals of tumor biology and of how tumor biology factors into medical decision-making.
- Identify barriers to patient involvement in clinical trials and ways to overcome them.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.